相似文献
1
Thrombocytopenia and leucopenia following carbutamide.
Br Med J. 1957 Jan 26;1(5012):199-204. doi: 10.1136/bmj.1.5012.199.
2
Occurrence of sensitivity and side reactions following carbutamide.
Diabetes. 1957 Jan-Feb;6(1):72-3; discussion, 85-90. doi: 10.2337/diab.6.1.72.
3
Effects of carbutamide in the diabetes associated with acromegaly.
Diabetes. 1957 Jan-Feb;6(1):70-2; discussion, 85-90. doi: 10.2337/diab.6.1.70.
4
Metabolic effects of carbutamide in selected diabetics.
Lancet. 1957 Mar 9;272(6967):504-7. doi: 10.1016/s0140-6736(57)90674-8.
5
A controlled trial of carbutamide in diabetic outpatients.
Diabetes. 1957 Jan-Feb;6(1):83-4; discussion, 85-90. doi: 10.2337/diab.6.1.83.
6
Clinical experience with carbutamide (BZ-55); a progress report.
Diabetes. 1957 Jan-Feb;6(1):74-7; discussion, 85-90. doi: 10.2337/diab.6.1.74.
7
New experimental and clinical results with BZ-55 (carbutamide) in Germany.
Diabetes. 1957 Jan-Feb;6(1):40-1; discussion, 43-5. doi: 10.2337/diab.6.1.40.
8
THIRD Lilly Conference on carbutamide; Indinapolis, Indiana, September 13-14, 1956.
Diabetes. 1957 Jan-Feb;6(1):1-94. doi: 10.2337/diab.6.1.1.
9
Metabolic effects of carbutamide in diabetes and interrelations with glucagon; a preliminary report.
Diabetes. 1957 Jan-Feb;6(1):45-53; discussion, 62. doi: 10.2337/diab.6.1.45.
10
The influence of carbutamide on thyroid function in older men and women with diabetes mellitus.
Diabetes. 1957 Jan-Feb;6(1):80-2; discussion, 85-90. doi: 10.2337/diab.6.1.80.
引用本文的文献
1
[THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].
Bull World Health Organ. 1964;31(1):95-100.
2
Tolbutamide in diabetes; some clinical and biochemical studies.
Br Med J. 1957 Aug 10;2(5040):327-31. doi: 10.1136/bmj.2.5040.327.
3
Glibenclamide causing thrombocytopenia and bleeding tendency: case reports and a review of the literature.
Klin Wochenschr. 1988 Mar 1;66(5):223-4. doi: 10.1007/BF01728201.
本文引用的文献
1
Three cases of thrombocytopenic purpura occurring after rubella; with a review of purpura associated with infections.
Q J Med. 1949 Oct;18(72):299-318, pl.
2
[Nadisan therapy of diabetes mellitus; trial therapy of 98 patients].
Dtsch Med Wochenschr. 1956 Aug 10;81(32):1278-80.
3
The role of sulphonylurea derivatives in the management of diabetes mellitus; a preliminary report.
Med J Aust. 1956 Jun 30;43(26):1072-8.
4
A clinical trial of BZ 55.
Br Med J. 1956 Aug 25;2(4990):433-9. doi: 10.1136/bmj.2.4990.433.
5
Insulin-sparing sulfonamides.
J Clin Endocrinol Metab. 1956 Jun;16(6):821-9. doi: 10.1210/jcem-16-6-821.
6
Clinical experiences with carbutamide, an orally given hypoglycemic agent; preliminary report.
J Am Med Assoc. 1956 Apr 14;160(15):1285-8. doi: 10.1001/jama.1956.02960500015005.
7
[An effective peroral anti-diabetic drug (BZ 55)].
Dtsch Med Wochenschr. 1955 Oct 7;80(40):1455-60. doi: 10.1055/s-0028-1116223.
8
[A new anti-diabetes principle; results of clinical research].
Dtsch Med Wochenschr. 1955 Oct 7;80(40):1449-52. doi: 10.1055/s-0028-1116221.
9
Tests for so-called capillary fragility of the skin and the significance of positive tests in vascular disease.
Am J Med. 1953 Aug;15(2):175-9. doi: 10.1016/0002-9343(53)90068-0.
Zotero 插件